SOURCE: Health Sciences Group, Inc

January 05, 2010 13:20 ET

Health Sciences Enters Into Negotiations for Colorado Medical Marijuana License

INDIAN HARBOR BEACH, FL--(Marketwire - January 5, 2010) - Health Sciences Group, Inc. (PINKSHEETS: HESG) would like to announce that it has engaged in negotiations with The Healing Center to assist with the acquisition of a Medical Marijuana license in the State of Colorado. "We believe that we will obtain the same sort of licensing agreement with The Healing Center as we did in Montana," said Health Sciences Group CEO Tom Gaffney.

Gaffney continues, "Our goal is to obtain proper and legal licenses in each of the legalized medical marijuana states during 2010. Once licensing is obtained we intend on raising capital to procure business in each of our licensed locations."

ABOUT HEALTH SCIENCES GROUP, INC.

Health Sciences Group, Inc. is a provider of health and wellness services to consumers, physicians and other healthcare professionals through its website, www.igohealthy.org, and health focused publications. The Health Sciences network consists of its public website, www.igohealthy.org, and iGoHealthy Magazine. The Company operates in three segments: Online Services, Publishing and Other Services. The Company is recently exploring options of corporate growth within the Legal Medical Marijuana Industry.

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Health Sciences Group, Inc. to be materially different from the statements made herein. Investors are highly advised to seek professional advice and conduct a complete due diligence regarding this, or any other company being considered for investment purposes. Investing in securities, particularly in issues priced at less than $1 per share, involves substantial risk and may result in a partial or complete loss of investment capital. Health Sciences Group, Inc., its subsidiaries, officers and employees cannot guarantee the completeness or accuracy of the information contained in company press releases or other company communications. Press releases and communications issued by the company should not be interpreted as an offer to sell or a solicitation to buy company stock. Investors are highly advised to seek professional advice and conduct a complete due diligence regarding this, or any other company being considered for investment purposes. Investing in securities, particularly in issues priced at less than $1 per share, involves substantial risk and may result in a partial or complete loss of investment capital. Health Sciences Group, Inc., its subsidiaries, officers and employees cannot guarantee the completeness or accuracy of the information contained in company press releases or other company communications. Press releases and communications issued by the company should not be interpreted as an offer to sell or a solicitation to buy company stock.

Contact Information

  • CONTACT:
    Health Sciences Group, Inc.

    Investor Relations
    Health Sciences Group, Inc.
    Frank Godleski
    IR Representative
    Email Contact: Email Contact